Cambridge Investment Research Advisors’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
29,685
+526
+2% +$19.4K ﹤0.01% 2133
2026
Q1
$1.01M Buy
29,159
+18,325
+169% +$585K ﹤0.01% 2158
2025
Q4
$282K Buy
10,834
+1,220
+13% +$30.3K ﹤0.01% 3259
2025
Q3
$253K Sell
9,614
-4,532
-32% -$109K ﹤0.01% 3270
2025
Q2
$351K Buy
14,146
+1,770
+14% +$43.4K ﹤0.01% 2850
2025
Q1
$325K Sell
12,376
-2,038
-14% -$55K ﹤0.01% 2787
2024
Q4
$359K Buy
14,414
+3,620
+34% +$83.8K ﹤0.01% 2693
2024
Q3
$218K Buy
+10,794
New +$219K ﹤0.01% 3078

Other funds holding AROC

Cambridge Investment Research Advisors's AROC Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Archrock (AROC) stake by 1.8% in Q2 2026, buying an estimated $19.4K and bringing the position to 29,685 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Cambridge Investment Research Advisors first reported a position in AROC in Q3 2024 and has held it in 8 quarters since. 450 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • Cambridge Investment Research Advisors held 29,685 shares of Archrock worth $1.21M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 526 Archrock shares in Q2 2026, an estimated $19.4K.
  • Archrock made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2133 holding.
  • Cambridge Investment Research Advisors first reported a position in Archrock in Q3 2024 and has held it in 8 quarters since.
  • 450 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.